Patiromer and Spironolactone in Resistant Hypertension and Advanced CKD: Analysis of the Randomized AMBER Trial. (2021)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.34067/kid.0006782020
PubMed Identifier: 35369022
Publication URI: http://europepmc.org/abstract/MED/35369022
Type: Journal Article/Review
Volume: 2
Parent Publication: Kidney360
Issue: 3
ISSN: 2641-7650